Market Tracker

04/17 6:05pm ET

Progenics Pharmaceuticals Inc (NASDAQ:PGNX)

3.50
Data as of Apr 17
 -0.06 / -1.69%
Today’s Change
3.20
Today|||52-Week Range
7.45
-34.33%
Year-to-Date
No recent news for Progenics Pharmaceuticals Inc.

Today’s Trading

Previous close3.56
Today’s open3.53
Day’s range3.44 - 3.73
Volume886,850
Average volume (3 months)1,448,175
Market cap$260.2M
Dividend yield--
Data as of 3:59pm ET, 04/17/2014

Growth & Valuation

Earnings growth (last year)+25.49%
Earnings growth (this year)+22.37%
Earnings growth (next 5 years)+7.00%
Revenue growth (last year)-44.03%
P/E ratioNM
Price/Sales37.83
Price/Book2.88

Competitors

 Today’s
change
Today’s
% change
CCXIChemoCentryx Inc+0.05+0.94%
POZNPOZEN Inc-0.03-0.34%
THLDThreshold Pharmaceut...-0.19-4.73%
NAVBNavidea Biopharmaceu...0.000.00%
Data as of 4:06pm ET, 04/17/2014

Financials

Next reporting dateMay 12, 2014
EPS forecast (this quarter)-$0.15
Annual revenue (last year)$7.9M
Annual profit (last year)-$42.6M
Net profit margin-541.49%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Mark Robert Baker
Chief Financial Officer, Treasurer, CAO &
VP
Angelo William Lovallo
Corporate headquarters
Tarrytown, New York

Forecasts